Option Care Health, Inc. 8-K

What Happened

• Option Care Health, Inc. (OPCH) issued a press release on January 12, 2026 announcing preliminary financial results for the three and twelve months ended December 31, 2025 and providing preliminary financial expectations for full-year 2026.
• The company is presenting at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 and furnished the investor presentation with the 8-K.
• On January 9, 2026, the Board approved increasing the company’s share repurchase authorization from $500 million to $1 billion; the program has no specified expiration and repurchases may be made in various manners.

Key Details

• Press release dated January 12, 2026 furnished as Exhibit 99.1; investor presentation dated January 13, 2026 furnished as Exhibit 99.2.
• Preliminary results cover the three- and twelve-month periods ended December 31, 2025 and include preliminary guidance/expectations for full-year 2026 (details in the furnished materials).
• Buyback authorization increased to $1.0 billion (previously $500 million); timing and amount of repurchases subject to management discretion and market/regulatory conditions.
• The furnished press release and presentation are included with the 8-K but are furnished (not “filed”) under applicable SEC rules.

Why It Matters

• The preliminary results and 2026 expectations give investors an early view of recent revenue/earnings trends and management’s outlook ahead of full audited filings.
• Doubling the repurchase authorization signals a stronger emphasis on returning capital to shareholders and could support per-share metrics if repurchases are executed.
• The JP Morgan presentation provides another channel for investors and analysts to hear management’s strategy and updated financial drivers; review the furnished materials for the detailed figures and guidance.